NCT04816890View on ClinicalTrials.gov

A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

February 24, 2022

Study Completion Date

February 24, 2022

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

M1 Pram P037

Subcutaneous administration of M1 Pram P037 in combination with a basal insulin.

DRUG

Insulin lispro

Subcutaneous administration of insulin lispro in combination with a basal insulin.

Trial Locations (2)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

55116

Profil Mainz GmbH & Co, Mainz

Sponsors

Lead Sponsor

Adocia
All Listed Sponsors
lead

Adocia

INDUSTRY

NCT04816890 - A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM) | Biotech Hunter | Biotech Hunter